Gyrodyne, LLC — FY2020 Form 10-K
Reporting period: Fiscal year ended December 31, 2020. Gyrodyne is a New York real estate owner and manager pursuing entitlements and sales of its remaining properties, with the stated intention to distribute residual proceeds and dissolve. Financial statements use the liquidation basis of accounting; conventional income-statement and cash-flow-statement totals are not presented.
Financial position and operating metrics
- Net assets in liquidation: $22.49 million, or an estimated $15.17 per share, at December 31, 2020, versus $31.37 million, or $21.16 per share, a year earlier.
- Real estate: Estimated net realizable value was $39.05 million, down $9.22 million from 2019. Management attributed the reduction to changed Cortlandt development plans and the cancelled sale contract there, as well as weaker Flowerfield values amid the pandemic and the termination of a Flowerfield sale agreement.
- Liquidity: Cash and cash equivalents were $1.63 million; restricted cash was $169,000. The filing reported $3.34 million of additional credit availability at year-end, including $800,000 restricted to certain capital improvements. The company drew another $1.09 million in January 2021.
- Debt: Mortgage loans payable were $5.16 million, up from $3.78 million at year-end 2019. Credit lines are secured by property; certain balances bear variable interest with a 4.75% floor. The company reported covenant compliance at December 31, 2020.
- Rental operations: 2020 receipts from rent and reimbursements were $2.43 million, versus $2.60 million in 2019; property operating costs were $1.51 million versus $1.54 million. Annual base rent at year-end was approximately $2.13 million. Portfolio occupancy was 75%, down from 82%, across 32 tenants versus 36.
- Cash uses and financing: The filing lists $1.01 million of 2020 entitlement costs, $2.10 million of corporate expenditures including interest, and $1.38 million of loan proceeds. The reported net change in assets is not operating profit: it primarily reflects liquidation-value remeasurement.
Material changes and notable events
- Net assets declined $8.88 million in 2020, compared with a $4.52 million increase in 2019. The 2020 change included a $9.22 million decrease in real estate value, partly offset by a $338,000 favorable remeasurement of other assets and liabilities.
- Two previously announced property transactions terminated after year-end: a $5.72 million Cortlandt sale contract was terminated on February 1, 2021, and a $16.8 million Flowerfield contract was terminated on March 16, 2021. Both buyers had contractual termination rights. The company said it would continue marketing the properties.
- A separate agreement to sell a non-contiguous five-acre Flowerfield parcel for $500,000 remained in process; approvals were obtained in March 2021 and the company anticipated a second-quarter 2021 closing.
- During 2020, four new leases were signed, but ten leases terminated; the reported net effect was a $137,700 decrease in annual lease commitments and 10,112 fewer rented square feet. Twenty-two renewals were signed.
Outlook, risks and contingencies
- Management estimated net assets of $22.49 million, or $15.17 per share, based on estimated asset proceeds and liquidation costs. Separately, it projected approximately $22.49 million of cash at December 31, 2022, before any future special distributions, assuming the plan proceeds on schedule. These are estimates, not promised distributions; actual amounts and timing depend on asset values, costs, claims, and Board decisions.
- The company expects to pursue entitlements and sell its remaining properties by December 31, 2022, but timing depends substantially on municipal approvals, buyers, and market conditions. It estimated approximately $1.5 million of additional entitlement costs through that date. It discontinued quantitative guidance on enhanced liquidation distributions, citing terminated sale contracts and uncertain local commercial real estate activity.
- Flowerfield subdivision review continued; its Final Environmental Impact Statement was accepted by the Town of Smithtown in March 2021. Cortlandt approvals remained pending, with the company anticipating a Medical Oriented District designation in early 2022. Neither outcome was assured.
- COVID-19 may affect tenant collections, occupancy, property values, approvals, and sale timing. Management noted that tenants representing about 37% of projected 2021 rental revenue were not-for-profit or neither medical nor affiliated with Stony Brook University or its hospital.
- The 2015 class-action settlement generally requires arm’s-length property sales at or above 2014 appraised values. This price floor may constrain sale options. Other key risks include entitlement delays or denial, tenant concentration, real estate illiquidity, interest-rate exposure, contingent liabilities, and the possibility that distributions could be reduced or eliminated. Shareholders could also face potential repayment liability if distributions leave insufficient funds for creditors.
- Management reported effective disclosure controls and internal control over financial reporting. The auditor issued an unqualified opinion and identified valuation of real estate under the liquidation basis as a critical audit matter.
Key facts for investors to verify
- Whether the $39.05 million estimated real estate value and $15.17-per-share net asset estimate remain supportable given the contract terminations and market changes.
- Progress and final outcomes of Flowerfield and Cortlandt entitlement, subdivision, and zoning processes, including costs and timing.
- Whether the five-acre Flowerfield sale closed, and whether replacement buyers emerge for the terminated $16.8 million and $5.72 million transactions.
- Actual debt balances, lender-controlled availability, loan conversion terms, collateral, and the impact of financing costs on liquidation proceeds.
- Tenant renewals, collections, occupancy, and concentration—particularly the largest tenants and leases scheduled to expire in 2021 and 2022.
- Changes to estimated liquidation expenses, deferred vendor fees, retention bonuses, creditor claims, or other reserves that could affect distributions.